Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 23.54 | 17.90 |
| PEG Ratio (TTM) | 2.75 | 2.17 |
| P/S Ratio (TTM) | 1.35 | 3.45 |
| P/B Ratio (TTM) | 1.37 | 2.07 |
| P/FCF Ratio (TTM) | -14.57 | -3.60 |
| Price to 5YR AVG Earnings Ratio | 19.35 | 8.50 |
| Price to 5YR AVG FCF Ratio | 14.51 | -160.02 |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.92% | -1.25% |
| ROE (TTM) | 5.92% | 9.78% |
| Net Profit Margin (TTM) | 5.98% | 17.26% |
| ROIC 5YR AVG | 11.68% | 10.98% |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 24.72% | 23.92% | 413.78% |
| Revenue | 22.65% | 25.97% | 16.40% |
| Net Income | 23.99% | 14.42% | -4.28% |
| Cash Flow | -342.58% | 113.76% | 26.83% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.82 | 2.60 |
| Quick Ratio (TTM) | 2.82 | 2.82 |
| D/E Ratio (TTM) | 2.07 | 3.58 |
| Interest Coverage (TTM) | 1.24 | 1.19 |
| Piotroski F-Score | 4 | 4 |
| Altman Z-Score | 1.15 | 1.46 |
| LTL to 5YR AVG FCF | 16.66 | -232.30 |
| Shares Outstanding Growth 5YR AVG | -5.43% | 2.38% |